PART and SNAP

go back to reference Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA (2009) Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. J Neurosci 29(6):1860–1873PubMedCentralPubMedCrossRef Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA (2009) Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. J Neurosci 29(6):1860–1873PubMedCentralPubMedCrossRef

go back to reference Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25(34):7709–7717PubMedCrossRef Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25(34):7709–7717PubMedCrossRef

go back to reference Chetelat G (2013) Alzheimer disease: abeta-independent processes-rethinking preclinical AD. Nat Rev Neurol 9(3):123–124. doi:10.1038/nrneurol.2013.21 PubMedCentralPubMedCrossRef Chetelat G (2013) Alzheimer disease: abeta-independent processes-rethinking preclinical AD. Nat Rev Neurol 9(3):123–124. doi:10.​1038/​nrneurol.​2013.​21 PubMedCentralPubMedCrossRef

go back to reference Chien DT, Bahri S, Szardenings AK, Walsh JC, Mu F, Su MY, Shankle WR, Elizarov A, Kolb HC (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis 34(2):457–468. doi:10.3233/JAD-122059 PubMed Chien DT, Bahri S, Szardenings AK, Walsh JC, Mu F, Su MY, Shankle WR, Elizarov A, Kolb HC (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis 34(2):457–468. doi:10.​3233/​JAD-122059 PubMed

go back to reference Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jicha GA, Jellinger KA, Kovacs GG, Knopman D, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee AC, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein TD, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL, 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. doi:10.1007/s00401-014-1349-0 Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jicha GA, Jellinger KA, Kovacs GG, Knopman D, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee AC, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein TD, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL, 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. doi:10.​1007/​s00401-014-1349-0

go back to reference Delacourte A, Sergeant N, Wattez A, Maurage CA, Lebert F, Pasquier F, David JP (2002) Tau aggregation in the hippocampal formation: an ageing or a pathological process? Exp Gerontol 37(10–11):1291–1296PubMedCrossRef Delacourte A, Sergeant N, Wattez A, Maurage CA, Lebert F, Pasquier F, David JP (2002) Tau aggregation in the hippocampal formation: an ageing or a pathological process? Exp Gerontol 37(10–11):1291–1296PubMedCrossRef

go back to reference Di Paola M, Caltagirone C, Fadda L, Sabatini U, Serra L, Carlesimo GA (2008) Hippocampal atrophy is the critical brain change in patients with hypoxic amnesia. Hippocampus 18(7):719–728. doi:10.1002/hipo.20432 PubMedCrossRef Di Paola M, Caltagirone C, Fadda L, Sabatini U, Serra L, Carlesimo GA (2008) Hippocampal atrophy is the critical brain change in patients with hypoxic amnesia. Hippocampus 18(7):719–728. doi:10.​1002/​hipo.​20432 PubMedCrossRef

go back to reference Duara R, Loewenstein DA, Shen Q, Barker W, Potter E, Varon D, Heurlin K, Vandenberghe R, Buckley C (2013) Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer’s disease. Alzheimers Dement 9(3):295–301. doi:10.1016/j.jalz.2012.01.006 PubMedCrossRef Duara R, Loewenstein DA, Shen Q, Barker W, Potter E, Varon D, Heurlin K, Vandenberghe R, Buckley C (2013) Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer’s disease. Alzheimers Dement 9(3):295–301. doi:10.​1016/​j.​jalz.​2012.​01.​006 PubMedCrossRef

go back to reference Duyckaerts C, Hauw JJ (1997) Prevalence, incidence and duration of Braak’s stages in the general population: can we know? Neurobiol Aging 18(4):362–369 (discussion 389–392)PubMedCrossRef Duyckaerts C, Hauw JJ (1997) Prevalence, incidence and duration of Braak’s stages in the general population: can we know? Neurobiol Aging 18(4):362–369 (discussion 389–392)PubMedCrossRef

go back to reference Duyckaerts C, Uchihara T, Seilhean D, He Y, Hauw JJ (1997) Dissociation of Alzheimer type pathology in a disconnected piece of cortex. Acta Neuropathol 93(5):501–507PubMedCrossRef Duyckaerts C, Uchihara T, Seilhean D, He Y, Hauw JJ (1997) Dissociation of Alzheimer type pathology in a disconnected piece of cortex. Acta Neuropathol 93(5):501–507PubMedCrossRef

go back to reference Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356PubMedCrossRef Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356PubMedCrossRef

go back to reference Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ (2012) National Institute on aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 8(1):1–13. doi:10.1016/j.jalz.2011.10.007 PubMedCentralPubMedCrossRef Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ (2012) National Institute on aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 8(1):1–13. doi:10.​1016/​j.​jalz.​2011.​10.​007 PubMedCentralPubMedCrossRef

go back to reference Ivanoiu A, Dricot L, Gilis N, Grandin C, Lhommel R, Quenon L, Hanseeuw B (2014) Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer’s disease with disease-related biomarkers. J Alzheimers Dis. doi:10.3233/JAD-140651 Ivanoiu A, Dricot L, Gilis N, Grandin C, Lhommel R, Quenon L, Hanseeuw B (2014) Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer’s disease with disease-related biomarkers. J Alzheimers Dis. doi:10.​3233/​JAD-140651

go back to reference Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carillo M, Thies W, Phelps CH (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):257–262PubMedCentralPubMedCrossRef Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carillo M, Thies W, Phelps CH (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):257–262PubMedCentralPubMedCrossRef

go back to reference Jack CR Jr, Dickson DW, Parisi JE, Xu YC, Cha RH, O’Brien PC, Edland SD, Smith GE, Boeve BF, Tangalos EG, Kokmen E, Petersen RC (2002) Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58(5):750–757PubMedCentralPubMedCrossRef Jack CR Jr, Dickson DW, Parisi JE, Xu YC, Cha RH, O’Brien PC, Edland SD, Smith GE, Boeve BF, Tangalos EG, Kokmen E, Petersen RC (2002) Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58(5):750–757PubMedCentralPubMedCrossRef

go back to reference Jack CR Jr, Holtzman DM (2013) Biomarker modeling of Alzheimer’s Disease. Neuron 80(6):1347–1358PubMedCrossRef Jack CR Jr, Holtzman DM (2013) Biomarker modeling of Alzheimer’s Disease. Neuron 80(6):1347–1358PubMedCrossRef

go back to reference Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick T, Pankratz VS, Donohue M, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12(2):207–216. doi:10.1016/S1474-4422(12)70291-0 PubMedCentralPubMedCrossRef Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick T, Pankratz VS, Donohue M, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12(2):207–216. doi:10.​1016/​S1474-4422(12)70291-0 PubMedCentralPubMedCrossRef

go back to reference Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts R, Rocca WA, Boeve BF, Petersen RC (2012) An operational approach to NIA–AA criteria for preclinical Alzheimer’s disease. Ann Neurol 71(6):765–775PubMedCentralPubMedCrossRef Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts R, Rocca WA, Boeve BF, Petersen RC (2012) An operational approach to NIA–AA criteria for preclinical Alzheimer’s disease. Ann Neurol 71(6):765–775PubMedCentralPubMedCrossRef

go back to reference Jack CR Jr, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, Senjem ML, Gunter JL, Lowe V, Gregg BE, Pankratz VS, Petersen RC (2014) Rates of beta-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology 82(18):1605–1612. doi:10.1212/WNL.0000000000000386 PubMedCentralPubMedCrossRef Jack CR Jr, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, Senjem ML, Gunter JL, Lowe V, Gregg BE, Pankratz VS, Petersen RC (2014) Rates of beta-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology 82(18):1605–1612. doi:10.​1212/​WNL.​0000000000000386​ PubMedCentralPubMedCrossRef

go back to reference Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Lowe V, Vemuri P, Mielke MM, Jones DT, Senjem ML, Gunter JL, Gregg BE, Pankratz VS, Petersen RC (2013) Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. Neurology 81(20):1732–1740. doi:10.1212/01.wnl.0000435556.21319.e4 PubMedCentralPubMedCrossRef Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Lowe V, Vemuri P, Mielke MM, Jones DT, Senjem ML, Gunter JL, Gregg BE, Pankratz VS, Petersen RC (2013) Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. Neurology 81(20):1732–1740. doi:10.​1212/​01.​wnl.​0000435556.​21319.​e4 PubMedCentralPubMedCrossRef

go back to reference Jack CR Jr, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, Lowe VJ, Senjem ML, Gunter JL, Preboske GM, Pankratz VS, Vemuri P, Petersen RC (2014) Age-specific population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study. Lancet Neurol 13(10):997–1005. doi:10.1016/S1474-4422(14)70194-2 PubMedCrossRef Jack CR Jr, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, Lowe VJ, Senjem ML, Gunter JL, Preboske GM, Pankratz VS, Vemuri P, Petersen RC (2014) Age-specific population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study. Lancet Neurol 13(10):997–1005. doi:10.​1016/​S1474-4422(14)70194-2 PubMedCrossRef

go back to reference Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Boeve BF, Petersen RC (2012) Short-term clinical outcomes for stages of NIA–AA preclinical Alzheimer disease. Neurology 78(20):1576–1582. doi:10.1212/WNL.0b013e3182563bbe PubMedCentralPubMedCrossRef Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Boeve BF, Petersen RC (2012) Short-term clinical outcomes for stages of NIA–AA preclinical Alzheimer disease. Neurology 78(20):1576–1582. doi:10.​1212/​WNL.​0b013e3182563bbe​ PubMedCentralPubMedCrossRef

go back to reference Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC (2013) Brain injury biomarkers are not dependent on beta-amyloid in normal elderly. Ann Neurol 73(4):472–480. doi:10.1002/ana.23816 PubMedCentralPubMedCrossRef Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC (2013) Brain injury biomarkers are not dependent on beta-amyloid in normal elderly. Ann Neurol 73(4):472–480. doi:10.​1002/​ana.​23816 PubMedCentralPubMedCrossRef

go back to reference Lowe VJ, Peller PJ, Weigand SD, Montoya Quintero C, Tosakulwong N, Vemuri P, Senjem ML, Jordan L, Jack CR Jr, Knopman D, Petersen RC (2013) Application of the National Institute on Aging-Alzheimer’s Association AD criteria to ADNI. Neurology 80(23):2130–2137. doi:10.1212/WNL.0b013e318295d6cf PubMedCentralPubMedCrossRef Lowe VJ, Peller PJ, Weigand SD, Montoya Quintero C, Tosakulwong N, Vemuri P, Senjem ML, Jordan L, Jack CR Jr, Knopman D, Petersen RC (2013) Application of the National Institute on Aging-Alzheimer’s Association AD criteria to ADNI. Neurology 80(23):2130–2137. doi:10.​1212/​WNL.​0b013e318295d6cf​ PubMedCentralPubMedCrossRef

go back to reference Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, Trojanowski JQ, Lee VM, Ono M, Masamoto K, Takano H, Sahara N, Iwata N, Okamura N, Furumoto S, Kudo Y, Chang Q, Saido TC, Takashima A, Lewis J, Jang MK, Aoki I, Ito H, Higuchi M (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79(6):1094–1108. doi:10.1016/j.neuron.2013.07.037 PubMedCrossRef Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, Trojanowski JQ, Lee VM, Ono M, Masamoto K, Takano H, Sahara N, Iwata N, Okamura N, Furumoto S, Kudo Y, Chang Q, Saido TC, Takashima A, Lewis J, Jang MK, Aoki I, Ito H, Higuchi M (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79(6):1094–1108. doi:10.​1016/​j.​neuron.​2013.​07.​037 PubMedCrossRef

go back to reference Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123(1):1–11. doi:10.1007/s00401-011-0910-3 PubMedCentralPubMedCrossRef Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123(1):1–11. doi:10.​1007/​s00401-011-0910-3 PubMedCentralPubMedCrossRef

go back to reference Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA (2014) Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. doi:10.1001/jamaneurol.2014.2031 Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA (2014) Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. doi:10.​1001/​jamaneurol.​2014.​2031

go back to reference Musiek ES, Holtzman DM (2012) Origins of Alzheimer’s disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement. Curr Opin Neurol 25(6):715–720. doi:10.1097/WCO.0b013e32835a30f4 PubMedCentralPubMedCrossRef Musiek ES, Holtzman DM (2012) Origins of Alzheimer’s disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement. Curr Opin Neurol 25(6):715–720. doi:10.​1097/​WCO.​0b013e32835a30f4​ PubMedCentralPubMedCrossRef

go back to reference Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH, Baker M, Fardo DW, Kryscio RJ, Scheff SW, Jicha GA, Jellinger KA, Van Eldik LJ, Schmitt FA (2013) Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 126(2):161–177. doi:10.1007/s00401-013-1154-1 PubMedCentralPubMedCrossRef Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH, Baker M, Fardo DW, Kryscio RJ, Scheff SW, Jicha GA, Jellinger KA, Van Eldik LJ, Schmitt FA (2013) Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 126(2):161–177. doi:10.​1007/​s00401-013-1154-1 PubMedCentralPubMedCrossRef

go back to reference Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, Mielke M, Pankratz VS, Roberts R, Rocca WA, Weigand S, Weiner M, Wiste H, Jack CR Jr (2013) Criteria for mild cognitive impairment due to Alzheimer’s disease in the community. Ann Neurol. doi:10.1002/ana.23931 Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, Mielke M, Pankratz VS, Roberts R, Rocca WA, Weigand S, Weiner M, Wiste H, Jack CR Jr (2013) Criteria for mild cognitive impairment due to Alzheimer’s disease in the community. Ann Neurol. doi:10.​1002/​ana.​23931

go back to reference Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Scholl M, Choo IH, Nordberg A, Scheltens P, Frisoni GB (2013) Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology 80(11):1048–1056. doi:10.1212/WNL.0b013e3182872830 PubMedCrossRef Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Scholl M, Choo IH, Nordberg A, Scheltens P, Frisoni GB (2013) Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology 80(11):1048–1056. doi:10.​1212/​WNL.​0b013e3182872830​ PubMedCrossRef

go back to reference Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 45(3):358–368PubMedCrossRef Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 45(3):358–368PubMedCrossRef

go back to reference Probst A, Taylor KI, Tolnay M (2007) Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol 114(4):335–345. doi:10.1007/s00401-007-0262-1 PubMedCrossRef Probst A, Taylor KI, Tolnay M (2007) Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol 114(4):335–345. doi:10.​1007/​s00401-007-0262-1 PubMedCrossRef

go back to reference Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TL, Mintun MA, Holtzman DM, Morris JC (2013) Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology 80(19):1784–1791. doi:10.1212/WNL.0b013e3182918ca6 PubMedCentralPubMedCrossRef Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TL, Mintun MA, Holtzman DM, Morris JC (2013) Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology 80(19):1784–1791. doi:10.​1212/​WNL.​0b013e3182918ca6​ PubMedCentralPubMedCrossRef

go back to reference Small SA, Duff K (2008) Linking Abeta and tau in late-onset Alzheimer’s disease: a dual pathway hypothesis. Neuron 60(4):534–542. doi:10.1016/j.neuron.2008.11.007 PubMedCentralPubMedCrossRef Small SA, Duff K (2008) Linking Abeta and tau in late-onset Alzheimer’s disease: a dual pathway hypothesis. Neuron 60(4):534–542. doi:10.​1016/​j.​neuron.​2008.​11.​007 PubMedCentralPubMedCrossRef

go back to reference Sperling RA, Laviolette PS, O’Keefe K, O’Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63(2):178–188PubMedCentralPubMedCrossRef Sperling RA, Laviolette PS, O’Keefe K, O’Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63(2):178–188PubMedCentralPubMedCrossRef

go back to reference Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ (2014) Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathol Commun 2(1):26. doi:10.1186/2051-5960-2-26 PubMedCentralPubMedCrossRef Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ (2014) Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathol Commun 2(1):26. doi:10.​1186/​2051-5960-2-26 PubMedCentralPubMedCrossRef

go back to reference Tsitsopoulos PP, Marklund N (2013) Amyloid-beta peptides and tau protein as biomarkers in cerebrospinal and interstitial fluid following traumatic brain injury: a review of experimental and clinical studies. Front Neurol 4:79. doi:10.3389/fneur.2013.00079 PubMedCentralPubMedCrossRef Tsitsopoulos PP, Marklund N (2013) Amyloid-beta peptides and tau protein as biomarkers in cerebrospinal and interstitial fluid following traumatic brain injury: a review of experimental and clinical studies. Front Neurol 4:79. doi:10.​3389/​fneur.​2013.​00079 PubMedCentralPubMedCrossRef

go back to reference van Harten AC, Smits LL, Teunissen CE, Visser PJ, Koene T, Blankenstein MA, Scheltens P, van der Flier WM (2013) Preclinical AD predicts decline in memory and executive functions in subjective complaints. Neurology 81(16):1409–1416. doi:10.1212/WNL.0b013e3182a8418b PubMedCrossRef van Harten AC, Smits LL, Teunissen CE, Visser PJ, Koene T, Blankenstein MA, Scheltens P, van der Flier WM (2013) Preclinical AD predicts decline in memory and executive functions in subjective complaints. Neurology 81(16):1409–1416. doi:10.​1212/​WNL.​0b013e3182a8418b​ PubMedCrossRef

go back to reference Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Dore V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N (2014) In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease. Eur J Nucl Med Mol Imaging 41(5):816–826. doi:10.1007/s00259-013-2681-7 PubMedCrossRef Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Dore V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N (2014) In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease. Eur J Nucl Med Mol Imaging 41(5):816–826. doi:10.​1007/​s00259-013-2681-7 PubMedCrossRef

go back to reference Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM (2013) Preclinical Alzheimer’s disease and its outcome: a longitudinal cohort study. Lancet Neurol 12(10):957–965. doi:10.1016/S1474-4422(13)70194-7 PubMedCentralPubMedCrossRef Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM (2013) Preclinical Alzheimer’s disease and its outcome: a longitudinal cohort study. Lancet Neurol 12(10):957–965. doi:10.​1016/​S1474-4422(13)70194-7 PubMedCentralPubMedCrossRef

go back to reference Whitwell JL, Jack CR Jr, Parisi JE, Senjem ML, Knopman DS, Boeve BF, Rademakers R, Baker M, Petersen RC, Dickson DW, Josephs KA (2010) Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? Neurology 75(24):2212–2220. doi:10.1212/WNL.0b013e31820203c2 PubMedCentralPubMedCrossRef Whitwell JL, Jack CR Jr, Parisi JE, Senjem ML, Knopman DS, Boeve BF, Rademakers R, Baker M, Petersen RC, Dickson DW, Josephs KA (2010) Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? Neurology 75(24):2212–2220. doi:10.​1212/​WNL.​0b013e31820203c2​ PubMedCentralPubMedCrossRef

go back to reference Whitwell JL, Josephs KA, Murray ME, Kantarci K, Przybelski SA, Weigand SD, Vemuri P, Senjem ML, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW, Jack CR Jr (2008) MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology 71(10):743–749PubMedCentralPubMedCrossRef Whitwell JL, Josephs KA, Murray ME, Kantarci K, Przybelski SA, Weigand SD, Vemuri P, Senjem ML, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW, Jack CR Jr (2008) MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology 71(10):743–749PubMedCentralPubMedCrossRef

go back to reference Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ (2013) Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol. doi:10.1001/jamaneurol.2013.4013 Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ (2013) Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol. doi:10.​1001/​jamaneurol.​2013.​4013

go back to reference Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, Chui HC (2005) Correlates of hippocampal neuron number in Alzheimer’s disease and ischemic vascular dementia. Ann Neurol 57(6):896–903PubMedCentralPubMedCrossRef Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, Chui HC (2005) Correlates of hippocampal neuron number in Alzheimer’s disease and ischemic vascular dementia. Ann Neurol 57(6):896–903PubMedCentralPubMedCrossRef